National surveillance of asthma: United States, 2001-2010.

National surveillance of asthma: United States, 2001-2010.
复制标题

DOI:
--
复制
发表时间:
2012-11
期刊:
Vital & health statistics. Series 3, Analytical and epidemiological studies
影响因子:
--
通讯作者:
J. Moorman;Lara J Akinbami;C. Bailey;H. Zahran;M. King;Carol A Johnson;Xiang Liu
J. Moorman;Lara J Akinbami;C. Bailey;H. Zahran;M. King;Carol A Johnson;Xiang Liu
中科院分区:
其他
文献类型:
--
作者:
J. Moorman;Lara J Akinbami;C. Bailey;H. Zahran;M. King;Carol A Johnson;Xiang Liu

文献摘要

被引文献

相似文献

背景哮喘很普遍,但可以治疗:坚持循证治疗可以减轻损害,降低未来病情恶化的风险。目的这份报告详细介绍了自2001年以来哮喘患病率、卫生保健使用和死亡率的最新趋势,并概述了自1980年以来的趋势。方法哮喘患病率估计值来自2001-2010年全国健康访谈调查。门诊就诊数据来源于《全国门诊医疗服务调查》,医院门急诊就诊数据来源于《全国医院门诊医疗服务调查》,住院数据来源于《全国医院出院调查》,死亡数据来源于《国家生命统计系统(2001-2009年)》。计算了两种类型的比率:基于总人口的基于人口的比率和基于哮喘人口的基于风险的比率。结果2001~2010年哮喘现患率呈上升趋势。医院门诊部就诊、急诊就诊或住院就诊的比率没有显著变化,而私人医生办公室就诊的基于风险的比率下降。从2001年到2009年,哮喘死亡率有所下降。从长期来看,2001年后哮喘患病率的上升速度慢于1980-1996年期间,哮喘住院人数自1984年以来下降,死亡人数自1999年以来下降。尽管出现了这些下降,但不良后果的种族和性别差异仍然很大。结论自2001年以来,哮喘患病率上升,基于风险的私人诊所就诊率和死亡率下降,其他类型的门诊就诊和住院的基于风险的比率没有明显的趋势。
BACKGROUND Asthma is prevalent but treatable: adherence to evidence-based treatment lessens impairment and lowers the risk of future exacerbations. OBJECTIVE This report details recent trends in asthma prevalence, health care use, and mortality since 2001 and presents an overview of trends since 1980. METHODS Asthma prevalence estimates were obtained from the National Health Interview Survey (2001-2010). Physician office visit data were obtained from the National Ambulatory Medical Care Survey, hospital outpatient department and emergency department (ED) visit data from the National Hospital Ambulatory Medical Care Survey, hospitalization data from the National Hospital Discharge Survey, and death data from the National Vital Statistics System (2001-2009). Two types of rates were calculated: population-based rates based on the total population and risk-based rates based on the population with asthma. RESULTS Current asthma prevalence increased from 2001 to 2010. There were no significant changes in rates for hospital outpatient department visits, ED visits, or hospitalizations, whereas risk-based rates for private physician office visits declined. Asthma death rates decreased from 2001 to 2009. Over the long term, asthma prevalence rose more slowly after 2001 than during 1980-1996, asthma hospitalizations declined since 1984 and deaths declined since 1999. Disparities by race and sex for adverse outcomes remained high despite these declines. CONCLUSION Since 2001, asthma prevalence increased, risk-based rates for visits to private physician offices and deaths declined, and risk-based rates for other types of ambulatory visits and for hospitalizations showed no clear trend.